Viewing Study NCT02123758


Ignite Creation Date: 2025-12-25 @ 12:24 AM
Ignite Modification Date: 2025-12-26 @ 11:49 PM
Study NCT ID: NCT02123758
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-05
First Post: 2014-04-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer
Sponsor: Aragon Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module